Protective effect of a novel and selective inhibitor of inducible nitric oxide synthase on experimental crescentic glomerulonephritis in WKY rats

Nephrology Dialysis Transplantation

Volumn 17, Issue 12, 2002, Pages 2117-2121

  Ogawa, Daisuke ^a   Shikata, Kenichi ^a   Matsuda, Mitsuhiro ^a   Okada, Shinichi ^a   Usui, Hitomi ^a   Wada, Jun ^a   Taniguchi, Naoyuki ^b   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Crescent; Glomerulonephritis; Inducible nitric oxide synthase; Macrophage; Nitric oxide; ONO 1714

Indexed keywords

7 CHLORO 3 IMINO 5 METHYL 2 AZA BICYCLO HEPTANE HYDROCHLORIDE; 7 CHLORO 3 IMINO 5 METHYL 2 AZABICYCLO[4.1.0]HEPTANE; AMIDINE; AMINOGUANIDINE; N(G) METHYLARGININE; NITRATE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; RADICAL; SODIUM CHLORIDE; UNCLASSIFIED DRUG; 7 CHLORO 3 IMINO 5 METHYL 2 AZABICYCLO(4.1.0)HEPTANE; 7-CHLORO-3-IMINO-5-METHYL-2-AZABICYCLO(4.1.0)HEPTANE; ENZYME INHIBITOR; FUSED HETEROCYCLIC RINGS; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; FEMALE; MACROPHAGE; METABOLITE; NONHUMAN; OSMOTIC PUMP; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RAT; RAT STRAIN; URINARY EXCRETION; ANIMAL; DRUG ANTAGONISM; ENZYMOLOGY; GLOMERULONEPHRITIS; GLOMERULUS; KIDNEY; PATHOLOGY; URINE; WISTAR KYOTO RAT;

AMIDINES; ANIMALS; DISEASE PROGRESSION; ENZYME INHIBITORS; GLOMERULONEPHRITIS; HETEROCYCLIC COMPOUNDS, 2-RING; KIDNEY; KIDNEY GLOMERULUS; NITRATES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PROTEINURIA; RATS; RATS, INBRED WKY;

EID: 0036900792     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.12.2117     Document Type: Article

References (20)

1. Wilcox CS, Welch WJ, Murad F et al. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci USA 1992; 89: 11993-11997
2. Harrison DG, Sayegh H, Ohara Y, Inoue N, Venema RC. Regulation of expression of the endothelial cell nitric oxide synthase. Clin Exp Pharmacol Physiol 1996; 23: 251-255
3. Kashem A, Endoh M, Yano N, Yamauchi F, Nomoto Y, Sakai H. Expression of inducible-NOS in human glomerulonephritis: the possible source is infiltrating monocytes/macrophages. Kidney Int 1996; 50: 392-399
4. Furusu A, Miyazaki M, Abe K et al. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int 1998; 53: 1760-1768
5. Goto S, Yamamoto T, Feng L et al. Expression and localization of inducible nitric oxide synthase in anti-Thy-1 glomerulonephritis. Am J Pathol 1995; 147: 1133-1141
6. Lefer AM. Nitric oxide: nature's naturally occurring leukocyte inhibitor. Circulation 1997; 95: 553-554
7. Lyons CR. The role of nitric oxide in inflammation. Adv Immunol 1995; 60: 323-371
8. Kushiro M, Shikata K, Sugimoto H et al. Therapeutic effects of prostacyclin analog on crescentic glomerulonephritis of rat. Kidney Int 1998; 53: 1314-1320
9. Naka M, Nanbu T, Kobayashi K et al. A potent inhibitor of inducible nitric oxide synthase, ONO-1714, a cyclic amidine derivative. Biochem Biophys Res Commun 2000; 270: 663-667
10. Kawasaki K, Yaoita E, Yamamoto T, Tamatani T, Miyasaka M, Kihara I. Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis. J Immunol 1993; 150: 1074-1083
11. Jansen A, Cook T, Taylor GM et al. Induction of nitric oxide synthase in rat immune complex glomerulonephritis. Kidney Int 1994; 45: 1215-1219
12. Heeringa P, van Goor H, Moshage H et al. Expression of iNOS, eNOS, and peroxynitrite-modified proteins in experimental anti-myeloperoxidase associated crescentic glomerulonephritis. Kidney Int 1998; 53: 382-393
13. Narita I, Border WA, Ketteler M, Noble NA. Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest 1995; 72: 17-24
14. Klahr S, Morrissey J. Renal disease: the two faces of nitric oxide. Lab Invest 1995; 72: 1-3
15. Okamoto I, Abe M, Shibata K et al. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture. Am J Respir Crit Care Med 2000; 162: 716-722
16. Naito Y, Takagi T, Ishikawa T et al. The inducible nitric oxide synthase inhibitor ONO-1714 blunts dextran sulfate sodium colitis in mice. Eur J Pharmacol 2001; 412: 91-99
17. Radi R, Rodriguez M, Castro L, Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 1994; 308: 89-95
18. Asahi M, Fujii J, Takao T et al. The oxidation of selenocysteine is involved in the inactivation of glutathione peroxidase by nitric oxide donor. J Biol Chem 1997; 272: 19152-19157
19. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 288: 481-487
20. Cattell V, Cook HT, Ebrahim H et al. Anti-GBM glomerulonephritis in mice lacking nitric oxide synthase type 2. Kidney Int 1998; 53: 932-936